{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:44:15Z","timestamp":1758815055544},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,1]]},"DOI":"10.7759\/cureus.63593","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T14:35:06Z","timestamp":1719844506000},"source":"Crossref","is-referenced-by-count":1,"title":["Dynamic Assessment of Hematological Parameters as Predictive Biomarkers for Disease Severity and Prognosis in COVID-19 Patients: A Longitudinal Study"],"prefix":"10.7759","author":[{"given":"Aparna P","family":"Patange","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jabbar V","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhupal","family":"Pujari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aparna","family":"Marwah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Animesh","family":"Dey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105924","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges","volume":"55","author":"Lai CC","year":"2020","unstructured":"Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020, 55:105924. 10.1016\/j.ijantimicag.2020.105924","journal-title":"Int J Antimicrob Agents"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.106054","article-title":"Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies","volume":"56","author":"Sharma A","year":"2020","unstructured":"Sharma A, Tiwari S, Deb MK, Marty JL. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies. Int J Antimicrob Agents. 2020, 56:106054. 10.1016\/j.ijantimicag.2020.106054","journal-title":"Int J Antimicrob Agents"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00028-20","article-title":"Coronavirus disease 2019 - COVID-19","volume":"33","author":"Dhama K","year":"2020","unstructured":"Dhama K, Khan S, Tiwari R, et al.. Coronavirus disease 2019 - COVID-19. Clin Microbiol Rev. 2020, 33:e00028-20. 10.1128\/CMR.00028-20","journal-title":"Clin Microbiol Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2021.153384","article-title":"Covid19, beyond just the lungs: a review of multisystemic involvement by Covid19","volume":"224","author":"Singh A","year":"2021","unstructured":"Singh A, Zaheer S, Kumar N, Singla T, Ranga S. Covid19, beyond just the lungs: a review of multisystemic involvement by Covid19. Pathol Res Pract. 2021, 224:153384. 10.1016\/j.prp.2021.153384","journal-title":"Pathol Res Pract"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.120.314515","article-title":"COVID-19 and respiratory system disorders: current knowledge, future clinical and translational research questions","volume":"40","author":"Brosnahan SB","year":"2020","unstructured":"Brosnahan SB, Jonkman AH, Kugler MC, Munger JS, Kaufman DA. COVID-19 and respiratory system disorders: current knowledge, future clinical and translational research questions. Arterioscler Thromb Vasc Biol. 2020, 40:2586-97. 10.1161\/ATVBAHA.120.314515","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.20-1536","article-title":"Hematological abnormalities in COVID-19: a narrative review","volume":"104","author":"Rahman A","year":"2021","unstructured":"Rahman A, Niloofa R, Jayarajah U, De Mel S, Abeysuriya V, Seneviratne SL. Hematological abnormalities in COVID-19: a narrative review. Am J Trop Med Hyg. 2021, 104:1188-201. 10.4269\/ajtmh.20-1536","journal-title":"Am J Trop Med Hyg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.30699\/IJP.2021.533645.2675","article-title":"Changes of routine hematological parameters in COVID-19 patients: correlation with imaging findings, RT-PCR and outcome","volume":"17","author":"Javadi A","year":"2022","unstructured":"Javadi A, Dabiri S, Meymandi MS, et al.. Changes of routine hematological parameters in COVID-19 patients: correlation with imaging findings, RT-PCR and outcome. Iran J Pathol. 2022, 17:37-47. 10.30699\/IJP.2021.533645.2675","journal-title":"Iran J Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2022.09.006","article-title":"SARS-CoV-2 in immunocompromised individuals","volume":"55","author":"DeWolf S","year":"2022","unstructured":"DeWolf S, Laracy JC, Perales, MA, Kamboj M, van den Brink MR, Vardhana S. SARS-CoV-2 in immunocompromised individuals. Immunity. 2022, 55:1779-98. 10.1016\/j.immuni.2022.09.006","journal-title":"Immunity"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2020.12.035","article-title":"Role of hematological parameters in the stratification of COVID-19 disease severity","volume":"62","author":"Taj S","year":"2021","unstructured":"Taj S, Kashif A, Arzinda Fatima S, Imran S, Lone A, Ahmed Q. Role of hematological parameters in the stratification of COVID-19 disease severity. Ann Med Surg (Lond). 2021, 62:68-72. 10.1016\/j.amsu.2020.12.035","journal-title":"Ann Med Surg (Lond)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/jpbs.JPBS_655_20","article-title":"Role of hematological and immunological parameters in COVID-19 patients","volume":"13","author":"Kumar A","year":"2021","unstructured":"Kumar A, Sepolia S, Shilpa RH, Rezayani G, Kumari S, Aastha, Gupta S. Role of hematological and immunological parameters in COVID-19 patients. J Pharm Bioallied Sci. 2021, 13:238-43. 10.4103\/jpbs.JPBS_655_20","journal-title":"J Pharm Bioallied Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00306","article-title":"Management of hemoglobin disorders during the COVID-19 pandemic","volume":"7","author":"Chowdhury SF","year":"2020","unstructured":"Chowdhury SF, Anwar S. Management of hemoglobin disorders during the COVID-19 pandemic. Front Med (Lausanne). 2020, 7:306. 10.3389\/fmed.2020.00306","journal-title":"Front Med (Lausanne)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S406658","article-title":"The diagnostic value of inflammatory markers (CRP, IL6, CRP\/IL6, CRP\/L, LCR) for assessing the severity of COVID-19 symptoms based on the MEWS and predicting the risk of mortality","volume":"16","author":"Wolszczak-Biedrzycka B","year":"2023","unstructured":"Wolszczak-Biedrzycka B, Dorf J, Milewska A, \u0141ukaszyk M, Naumnik W, Kosid\u0142o JW, Dymicka-Piekarska V. The diagnostic value of inflammatory markers (CRP, IL6, CRP\/IL6, CRP\/L, LCR) for assessing the severity of COVID-19 symptoms based on the MEWS and predicting the risk of mortality. J Inflamm Res. 2023, 16:2173-88. 10.2147\/JIR.S406658","journal-title":"J Inflamm Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10081556","article-title":"Coronavirus disease 2019-associated coagulopathy","volume":"10","author":"Seo JW","year":"2022","unstructured":"Seo JW, Kim DY, Yun N, Kim DM. Coronavirus disease 2019-associated coagulopathy. Microorganisms. 2022, 10:1556. 10.3390\/microorganisms10081556","journal-title":"Microorganisms"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.8583","article-title":"Coronavirus disease 2019 (COVID-19)-associated thromboembolic disease: a report of three patients with pulmonary embolism","volume":"12","author":"Guccione J","year":"2020","unstructured":"Guccione J, Ocazionez D, Aisenberg G, Odisio E. Coronavirus disease 2019 (COVID-19)-associated thromboembolic disease: a report of three patients with pulmonary embolism. Cureus. 2020, 12:e8583. 10.7759\/cureus.8583","journal-title":"Cureus"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s43168-021-00075-w","article-title":"Prognostic biomarkers in COVID-19 infection: value of anemia, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and D-dimer","volume":"15","author":"Hashem MK","year":"2021","unstructured":"Hashem MK, Khedr EM, Daef E, et al.. Prognostic biomarkers in COVID-19 infection: value of anemia, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and D-dimer. Egypt J Bronchol. 2021, 15:29. 10.1186\/s43168-021-00075-w","journal-title":"Egypt J Bronchol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/idr13040085","article-title":"Prognostic role of anemia in COVID-19 patients: a meta-analysis","volume":"13","author":"Zuin M","year":"2021","unstructured":"Zuin M, Rigatelli G, Quadretti L, Fogato L, Zuliani G, Roncon L. Prognostic role of anemia in COVID-19 patients: a meta-analysis. Infect Dis Rep. 2021, 13:930-7. 10.3390\/idr13040085","journal-title":"Infect Dis Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1098547","article-title":"The oxygen dissociation curve of blood in COVID-19 - an update","volume":"10","author":"B\u00f6ning D","year":"2023","unstructured":"B\u00f6ning D, Kuebler WM, Vogel D, Bloch W. The oxygen dissociation curve of blood in COVID-19 - an update. Front Med (Lausanne). 2023, 10:1098547. 10.3389\/fmed.2023.1098547","journal-title":"Front Med (Lausanne)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10081545","article-title":"Systemic inflammation and COVID-19 mortality in patients with major noncommunicable diseases: chronic coronary syndromes, diabetes and obesity","volume":"10","author":"Buicu AL","year":"2021","unstructured":"Buicu AL, Cernea S, Benedek I, Buicu CF, Benedek T. Systemic inflammation and COVID-19 mortality in patients with major noncommunicable diseases: chronic coronary syndromes, diabetes and obesity. J Clin Med. 2021, 10:1545. 10.3390\/jcm10081545","journal-title":"J Clin Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1080\/14787210.2021.1915129","article-title":"Cytokine storm associated coagulation complications in COVID-19 patients: pathogenesis and management","volume":"19","author":"Savla SR","year":"2021","unstructured":"Savla SR, Prabhavalkar KS, Bhatt LK. Cytokine storm associated coagulation complications in COVID-19 patients: pathogenesis and management. Expert Rev Anti Infect Ther. 2021, 19:1397-413. 10.1080\/14787210.2021.1915129","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyab012","article-title":"The role of C-reactive protein as a prognostic marker in COVID-19","volume":"50","author":"Stringer D","year":"2021","unstructured":"Stringer D, Braude P, Myint PK, et al.. The role of C-reactive protein as a prognostic marker in COVID-19. Int J Epidemiol. 2021, 50:420-9. 10.1093\/ije\/dyab012","journal-title":"Int J Epidemiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01316-9","article-title":"COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches","volume":"22","author":"Kakavandi S","year":"2024","unstructured":"Kakavandi S, Hajikhani B, Azizi P, et al.. COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches. Cell Commun Signal. 2024, 22:126. 10.1186\/s12964-023-01316-9","journal-title":"Cell Commun Signal"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2021.11.027","article-title":"Sustained inflammation, coagulation activation and elevated endothelin-1 levels without macrovascular dysfunction at 3\u00a0months after COVID-19","volume":"209","author":"Willems LH","year":"2022","unstructured":"Willems LH, Nagy M, Ten Cate H, et al.. Sustained inflammation, coagulation activation and elevated endothelin-1 levels without macrovascular dysfunction at 3\u00a0months after COVID-19. Thromb Res. 2022, 209:106-14. 10.1016\/j.thromres.2021.11.027","journal-title":"Thromb Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4081\/cp.2020.1271","article-title":"COVID-19: hemoglobin, iron, and hypoxia beyond inflammation. A narrative review","volume":"10","author":"Cavezzi A","year":"2020","unstructured":"Cavezzi A, Troiani E, Corrao S. COVID-19: hemoglobin, iron, and hypoxia beyond inflammation. A narrative review. Clin Pract. 2020, 10:1271. 10.4081\/cp.2020.1271","journal-title":"Clin Pract"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/263127-dynamic-assessment-of-hematological-parameters-as-predictive-biomarkers-for-disease-severity-and-prognosis-in-covid-19-patients-a-longitudinal-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T14:35:10Z","timestamp":1719844510000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/263127-dynamic-assessment-of-hematological-parameters-as-predictive-biomarkers-for-disease-severity-and-prognosis-in-covid-19-patients-a-longitudinal-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,1]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.63593","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,1]]}}}